Presents the complicated process of CNS drug development in a way that is engaging and informative for professionals and students.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Amir Kalali is Vice President, Medical and Scientific Services, and Global Therapeutic Team Leader (CNS) at Quintiles Inc. He is also Professor of Psychiatry at the University of California San Diego, San Diego, CA, USA.
Sheldon Preskorn is Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita, KS, USA.
Joseph Kwentus is Clinical Professor at the University of Mississippi Medical Center, Jackson, MS, USA.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Buchmarie, Darmstadt, Deutschland
Zustand: Good. Artikel-Nr. 3294823_3cf_3x
Anzahl: 1 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780521766067_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Presents the complicated process of CNS drug development in a way that is engaging and informative for professionals and students. Editor(s): Kalali, Amir; Kwentus, Joseph; Friedman, Loren; Preskorn, Sheldon H.; Stahl, Stephen M. Num Pages: 215 pages, 27 b/w illus. 5 colour illus. 23 tables. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 15. Weight in Grams: 520. . 2012. New. hardcover. . . . . Books ship from the US and Ireland. Artikel-Nr. V9780521766067
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 218 pages. 9.37x6.14x0.63 inches. In Stock. Artikel-Nr. x-0521766060
Anzahl: 2 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians. Artikel-Nr. 9780521766067
Anzahl: 1 verfügbar